Condensed Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net revenue	$ 360,990	$ 479,375	$ 1,087,027	$ 1,419,444
Operating expenses
Cost of revenue	205,464	238,984	617,247	695,868
Research and development	59,966	64,160	192,647	191,984
Selling, general and administrative	68,036	68,467	208,881	209,593
Acquisition-related charges	1,530	1,019	5,442	3,069
Restructuring charges		0	(12,950)	(21,210)
Restructuring credit	(1,404)
Credit from reserved grant income	0	0	(10,689)	0
Gain on sale of assets	0	(33,428)	0	(35,310)
Total operating expenses	333,592	339,202	1,026,478	1,086,414
Income from operations	27,398	140,173	60,549	333,030
Interest and other income (expense), net	153	(264)	(3,787)	918
Income before income taxes	27,551	139,909	56,762	333,948
Provision for income taxes	(5,915)	(23,203)	(13,985)	(51,819)
Net income	$ 21,636	$ 116,706	$ 42,777	$ 282,129
Basic net income per share:
Net income per share (in dollars per share)	$ 0.05	$ 0.25	$ 0.10	$ 0.62
Weighted-average shares used in basic net income per share calculations (in shares)	430,845	457,721	434,894	456,992
Diluted net income per share:
Net income per share (in dollars per share)	$ 0.05	$ 0.25	$ 0.10	$ 0.60
Weighted-average shares used in diluted net income per share calculations (in shares)	433,295	466,862	438,232	467,040